Scholars Central

Conference abstractPublished 27 Oct 2014

Formulation and evaluation of telmisartan fast dissolving tablets using liqui-solid technology

Authors: Sindhu Reddy Musipatla

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Telmisartan is an Angiotensin receptor blocker which comes under BCS class-2. Liquisolid technique is a novel approach for FDT. Formulation of drug includes API (Telmisartan) and excipients like binders, glidants, superdisintegrants, lubricants and non-volatile solvents. The main theme of formulation is to disintegrate the tablet within seconds. Evaluation is carried out by pre compression parameters and post compression parameters, solubility studies, bioavailability and bioequivalence studies, drug excipient compatibility studies, disintegration and dissolution parameters, wetting time, water absorption ratio. Analysis of drug using HPLC, IR and stability of drug is performed as per ICH guidelines. Comparison of formulation with conventional dosage forms which results in better drug release in pH 7.4 phosphate buffer.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sindhu Reddy Musipatla”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels